Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Look What the Koch Brothers Are Buying Now

Page 1 of 2

Conservative billionaires and liberal bugaboos Charles and David Koch are believed to have spent nearly $100 million on the 2012 elections, hoping to deny President Obama a second term. With the president firmly in office today, that investment appears to have been largely lost — money down the drain.

But did you know the Kochs have just made another investment that could result in even bigger losses?

Barack Obama serious

A roundabout investment in Apple
Earlier this month, The Wall Street Journal reported that Koch Industries, the Wichita, Kan.-based industrial conglomerate owned by the Koch brothers, agreed to pay $7.2 billion to acquire electronics manufacturer Molex Incorporated (NASDAQ:MOLX) .

If you haven’t heard of Molex, that’s not surprising. While a big company, it mainly operates as a parts supplier to even bigger companies. You’ve probably heard of Molex’s biggest customer — Apple Inc. (NASDAQ:AAPL). Last year, 14% of the revenues Molex took in depended on sales to the Cupertino computing giant. That’s more than Molex got from any other single customer, none of which accounted for more than 10% of sales. A bet on Molex, therefore, is at least in part a bet on continued sales success for Apple.

Considering the sellout success of Apple’s new iPhone 5s, that may sound like a good bet. But there are at least a few reasons to suspect that the Kochs’ latest investment won’t work out as planned.

Molex: by the numbers
Let’s start with the most obvious objection to Koch Industries’ purchase of Molex: the price. Offering $7.2 billion for Molex, the Kochs are agreeing to pay close to two times sales for their new acquisition. That’s not a whole lot less than Apple itself costs (2.5 times sales). Yet Molex is a whole lot less profitable an operation than its marquee customer.

Operating profit margins at Molex were just over 10.2% for the past year (and trending lower), versus the 29.5% operating margin that Apple gets on its sales. On a P/E basis, Molex looks quite overpriced — valued at 28.5 times earnings at today’s share price, and nearly 30 times earnings at the price the Kochs have agreed to pay for it. (Apple’s P/E — just 11.6).

Molex: Better numbers coming?
Granted, Molex is working hard to bring up its earnings and bring down its P/E. The company has a stated objective of achieving 14% operating margins at some point in the future. Last quarter, though, its operating margin dipped to 9.4%. And with Apple aiming to lower the prices of some smartphones to compete against cheaper Android wares, it seems to me Molex’s margins are more likely to get squeezed further than to expand.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!